Genmab — Januar 2017
-
-
Morphosys er foran Genmab i NHL. De har allerede en mor208-kombi i fase 3 mod DLBCL. https://www.clinicaltrials.gov/ct2/show/NCT02763319?term=mor208&rank=1
-
Kan sagtens forestille mig et fald enten generelt eller rettet mod Genmab til opsamling af stop loss, men der vil starte en positionering frem mod 18 jan. - om den er startet eller først starter næste uge ved jeg ikke, men nogen vil positionere sig inkl. mig selv.
-
Danske: Køb bare Pharma.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
